NeoGenomics, Inc.
NEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $660,566 | $591,643 | $509,728 | $484,329 |
| % Growth | 11.6% | 16.1% | 5.2% | – |
| Cost of Goods Sold | $370,466 | $347,039 | $321,832 | $297,269 |
| Gross Profit | $290,100 | $244,604 | $187,896 | $187,060 |
| % Margin | 43.9% | 41.3% | 36.9% | 38.6% |
| R&D Expenses | $31,159 | $27,309 | $30,326 | $21,873 |
| G&A Expenses | $225,868 | $209,117 | $210,585 | $221,347 |
| SG&A Expenses | $310,493 | $279,959 | $277,906 | $283,941 |
| Sales & Mktg Exp. | $84,625 | $70,842 | $67,321 | $62,594 |
| Other Operating Expenses | $40,554 | $45,072 | $37,287 | $0 |
| Operating Expenses | $382,206 | $352,340 | $345,519 | $305,814 |
| Operating Income | -$92,106 | -$107,736 | -$157,623 | -$118,754 |
| % Margin | -13.9% | -18.2% | -30.9% | -24.5% |
| Other Income/Exp. Net | $11,431 | $10,639 | -$1,719 | $103,679 |
| Pre-Tax Income | -$80,675 | -$97,097 | -$159,342 | -$15,075 |
| Tax Expense | -$1,949 | -$9,129 | -$15,092 | -$6,728 |
| Net Income | -$78,726 | -$87,968 | -$144,250 | -$8,347 |
| % Margin | -11.9% | -14.9% | -28.3% | -1.7% |
| EPS | -3.1 | -3.5 | -5.8 | -0.35 |
| % Growth | 11.4% | 39.7% | -1,557.1% | – |
| EPS Diluted | -3.1 | -3.5 | -5.8 | -0.35 |
| Weighted Avg Shares Out | 25,332 | 25,100 | 24,843 | 23,992 |
| Weighted Avg Shares Out Dil | 25,332 | 25,100 | 24,843 | 23,992 |
| Supplemental Information | – | – | – | – |
| Interest Income | $18,427 | $16,902 | $6,075 | $3,138 |
| Interest Expense | $6,617 | $6,907 | $7,581 | $8,220 |
| Depreciation & Amortization | $72,547 | $72,583 | $69,430 | $53,352 |
| EBITDA | -$1,511 | -$17,607 | -$82,331 | -$65,402 |
| % Margin | -0.2% | -3% | -16.2% | -13.5% |